ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $440,000 | +14.3% | 138,459 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $385,000 | -46.8% | 138,459 | -24.7% | 0.01% | -45.5% |
| Q1 2016 | $724,000 | -60.5% | 183,806 | -1.3% | 0.01% | -50.0% |
| Q4 2015 | $1,831,000 | -49.7% | 186,299 | -47.5% | 0.02% | -55.1% |
| Q3 2015 | $3,639,000 | -36.4% | 354,659 | +14.8% | 0.05% | -39.5% |
| Q2 2015 | $5,720,000 | – | 308,859 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
| EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
| TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
| Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
| Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
| TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
| Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
| Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |